These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35665859)
1. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center. Raghunathan NJ; Brens J; Vemuri S; Li QS; Mao JJ; Korenstein D Support Care Cancer; 2022 Sep; 30(9):7491-7497. PubMed ID: 35665859 [TBL] [Abstract][Full Text] [Related]
2. Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients. Nathan R; Mupamombe CT; Elibol J; Case AA; Smith D; Hyland A; Attwood K; Hansen ED Am J Hosp Palliat Care; 2023 Apr; 40(4):368-373. PubMed ID: 35749740 [TBL] [Abstract][Full Text] [Related]
3. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite. Spanagel R; Bilbao A Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977 [TBL] [Abstract][Full Text] [Related]
4. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study. Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169 [TBL] [Abstract][Full Text] [Related]
5. Use of Cannabis and Cannabinoids in Patients With Cancer. Sawtelle L; Holle LM Ann Pharmacother; 2021 Jul; 55(7):870-890. PubMed ID: 33070617 [TBL] [Abstract][Full Text] [Related]
6. Clinical uses of cannabis and cannabinoids in the United States. Levinsohn EA; Hill KP J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684 [TBL] [Abstract][Full Text] [Related]
7. Mapping cannabis potency in medical and recreational programs in the United States. Cash MC; Cunnane K; Fan C; Romero-Sandoval EA PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334 [TBL] [Abstract][Full Text] [Related]
8. Cannabis-based medicines and medical cannabis for adults with cancer pain. Häuser W; Welsch P; Radbruch L; Fisher E; Bell RF; Moore RA Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014915. PubMed ID: 37283486 [TBL] [Abstract][Full Text] [Related]
9. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population. Highet BH; Lesser ER; Johnson PW; Kaur JS Am J Hosp Palliat Care; 2020 Aug; 37(8):589-593. PubMed ID: 31986898 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Rice J; Cameron M Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Legare CA; Raup-Konsavage WM; Vrana KE Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949 [TBL] [Abstract][Full Text] [Related]
12. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada. Hammond D; Goodman S Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866 [No Abstract] [Full Text] [Related]
13. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826 [TBL] [Abstract][Full Text] [Related]
14. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients. Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776 [No Abstract] [Full Text] [Related]
15. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy]. Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763 [TBL] [Abstract][Full Text] [Related]
16. Homegrown perceptions about the medical use and potential abuse of CBD and THC. McFadden BR; Malone T Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use. Kalaba M; Ware MA Cannabis Cannabinoid Res; 2022 Dec; 7(6):840-851. PubMed ID: 33999649 [No Abstract] [Full Text] [Related]
18. Cannabis-Based Products for Chronic Pain : A Systematic Review. McDonagh MS; Morasco BJ; Wagner J; Ahmed AY; Fu R; Kansagara D; Chou R Ann Intern Med; 2022 Aug; 175(8):1143-1153. PubMed ID: 35667066 [TBL] [Abstract][Full Text] [Related]